Transfer of Autologous Gene-modified T Cells in HIV-infected Patients with Advanced Immunodeficiency and Drug-resistant Virus
Open Access
- 1 May 2007
- journal article
- clinical trial
- Published by Elsevier in Molecular Therapy
- Vol. 15 (5) , 1024-1033
- https://doi.org/10.1038/mt.sj.6300124
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Gene transfer in humans using a conditionally replicating lentiviral vectorProceedings of the National Academy of Sciences, 2006
- Gene therapy for HIV infection: what does it need to make it work?The Journal of Gene Medicine, 2006
- Membrane-Anchored Inhibitory Peptides Capture Human Immunodeficiency Virus Type 1 gp41 Conformations That Engage the Target Membrane prior to FusionJournal of Virology, 2006
- CD4+ T cell receptor repertoire perturbations in HIV-1 infection: Association with plasma viremia and disease progressionClinical Immunology, 2006
- Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived PeptidesJournal of Virology, 2004
- Side effects of retroviral gene transfer into hematopoietic stem cellsBlood, 2003
- Antiretroviral-Drug Resistance among Patients Recently Infected with HIVNew England Journal of Medicine, 2002
- Membrane-Anchored Peptide Inhibits Human Immunodeficiency Virus EntryJournal of Virology, 2001
- Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapyNature Medicine, 1998
- HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapiesNature Medicine, 1997